EZH2 is essential for development of mouse preimplantation embryos

被引:38
作者
Huang, Xian-Ju [1 ]
Wang, Xuguang [1 ,2 ]
Ma, Xueshan [1 ,3 ]
Sun, Shao-Chen [1 ]
Zhou, Xiaolong [1 ]
Zhu, Chengcheng [1 ]
Liu, Honglin [1 ]
机构
[1] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing 210095, Jiangsu, Peoples R China
[2] Xinjiang Agr Univ, Anim Sci Coll, Xinjiang 830052, Peoples R China
[3] Peking Univ, Peoples Hosp, Chinese Acad Sci, State Key Lab Reprod Biol,Inst Zool, Beijing 100101, Peoples R China
关键词
de novo; growth retardation; histone modification; HISTONE METHYLTRANSFERASE ACTIVITY; H3; LYSINE-27; METHYLATION; GROUP PROTEIN EED; STEM-CELLS; CHROMATIN-STRUCTURE; POLYCOMB; HETEROCHROMATIN; PLURIPOTENCY; MAINTENANCE; COMPLEXES;
D O I
10.1071/RD13169
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Enhancer of zeste homologue 2 (Ezh2) is essential for the development of the early mouse preimplantation embryo. Loss of Ezh2 results in embryonic lethality in mice. Ezh2-deficient embryos display impaired outgrowth potential, defective establishment of Ezh2-null embryonic stem (ES) cells and adherence and differentiation of the trophoblast layer into giant cells. We investigated if Ezh2 controls the fate of embryos at an earlier stage by treating with cycloheximide (CHX) or microinjecting short interfering RNA (siRNA) to restrict embryonic Ezh2 expression during preimplantation. CHX inhibited de novo EZH2 protein synthesis in zygotes, suggesting that EZH2 requires de novo synthesis during post-fertilisation stages. We found that loss of Ezh2 at the pronuclear stage caused severe growth retardation and reduced blastocyst formation. Expression of the pluripotency-associated markers Oct4, Sox2 and Nanog were significantly decreased in embryos that had been injected with Ezh2 siRNA. In addition, Ezh2 loss induced upregulated expression of genes related to the differentiation of germ layers, including Gata6, Hoxb1 and Hand1. Finally, apoptosis was increased in the blastocyst embryos with Ezh2 knockdown. Modification of histone H3-Lysine 27 de-methylation and tri-methylation (H3K27me2/3) was strongly reduced in Ezh2 siRNA embryos. We conclude that Ezh2 is essential for early preimplantation embryo development through the regulation of epigenetic modification and apoptosis.
引用
收藏
页码:1166 / 1175
页数:10
相关论文
共 50 条
  • [31] Inhibition of Ezh2 In Vitro and the Decline of Ezh2 in Developing Midbrain Promote Dopaminergic Neurons Differentiation Through Modifying H3K27me3
    Hong, Feng
    Zhao, Mengxue
    Zhang, Lei
    Feng, Linyin
    STEM CELLS AND DEVELOPMENT, 2019, 28 (10) : 649 - 658
  • [32] EZH2 in Myeloid Malignancies
    Rinke, Jenny
    Chase, Andrew
    Cross, Nicholas C. P.
    Hochhaus, Andreas
    Ernst, Thomas
    CELLS, 2020, 9 (07)
  • [33] Dissecting and targeting noncanonical functions of EZH2 in multiple myeloma via an EZH2 degrader
    Yu, Xufen
    Wang, Jun
    Gong, Weida
    Ma, Anqi
    Shen, Yudao
    Zhang, Chengwei
    Liu, Xijuan
    Cai, Ling
    Liu, Jing
    Wang, Gang Greg
    Jin, Jian
    ONCOGENE, 2023, 42 (13) : 994 - 1009
  • [34] JAK3-mediated phosphorylation of EZH2: a novel mechanism of non-canonical EZH2 activation and oncogenic function
    Karantanos, Theodoros
    Boussiotis, Vassiliki A.
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1208 - S1211
  • [35] PCAF-primed EZH2 acetylation regulates its stability and promotes lung adenocarcinoma progression
    Wan, Junhu
    Zhan, Jun
    Li, Shuai
    Ma, Ji
    Xu, Weizhi
    Liu, Chang
    Xue, Xiaowei
    Xie, Yuping
    Fang, Weigang
    Chin, Y. Eugene
    Zhang, Hongquan
    NUCLEIC ACIDS RESEARCH, 2015, 43 (07) : 3591 - 3604
  • [36] Essential role of paternal chromatin in the regulation of transcriptional activity during mouse preimplantation development
    Bui, Hong-Thuy
    Wakayama, Sayaka
    Mizutani, Eiji
    Park, Keun-Kyu
    Kim, Jin-Hoi
    Van Thuan, Nguyen
    Wakayama, Teruhiko
    REPRODUCTION, 2011, 141 (01) : 67 - 77
  • [37] Inhibition of EZH2 Reduces Aging-Related Decline in Interstitial Cells of Cajal of the Mouse Stomach
    Taheri, Negar
    Choi, Egan L.
    Nguyen, Vy Truong Thuy
    Zhang, Yuebo
    Huynh, Nick M.
    Kellogg, Todd A.
    van Wijnen, Andre J.
    Ordog, Tamas
    Hayashi, Yujiro
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2024, 18 (04):
  • [38] EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
    Beguelin, Wendy
    Popovic, Relja
    Teater, Matt
    Jiang, Yanwen
    Bunting, Karen L.
    Rosen, Monica
    Shen, Hao
    Yang, Shao Ning
    Wang, Ling
    Ezponda, Teresa
    Martinez-Garcia, Eva
    Zhang, Haikuo
    Zheng, Yupeng
    Verma, Sharad K.
    McCabe, Michael T.
    Ott, Heidi M.
    Van Aller, Glenn S.
    Kruger, Ryan G.
    Liu, Yan
    McHugh, Charles F.
    Scott, David W.
    Chung, Young Rock
    Kelleher, Neil
    Shaknovich, Rita
    Creasy, Caretha L.
    Gascoyne, Randy D.
    Wong, Kwok-Kin
    Cerchietti, Leandro
    Levine, Ross L.
    Abdel-Wahab, Omar
    Licht, Jonathan D.
    Elemento, Olivier
    Melnick, Ari M.
    CANCER CELL, 2013, 23 (05) : 677 - 692
  • [39] Discovery of dihydropyridinone derivative as a covalent EZH2 degrader
    Zhou, Bin
    Wang, Beilei
    Zou, Fengming
    Mei, Husheng
    Liu, Qingwang
    Qi, Shuang
    Wang, Wenliang
    Jin, Rui
    Wang, Aoli
    Chen, Yongfei
    Liu, Feiyang
    Wang, Wenchao
    Liu, Jing
    Liu, Qingsong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
  • [40] Targeting histone methyltransferase EZH2 as cancer treatment
    Kondo, Yutaka
    JOURNAL OF BIOCHEMISTRY, 2014, 156 (05) : 249 - 257